FR2718450B1
(fr)
*
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
FR2719587B1
(fr)
*
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
FR2727969B1
(fr)
*
|
1994-12-09 |
1997-01-17 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2732023B1
(fr)
*
|
1995-03-22 |
1997-04-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2732684B1
(fr)
*
|
1995-04-06 |
1997-04-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
US5747466A
(en)
*
|
1995-11-08 |
1998-05-05 |
Abbott Laboratories |
3-deoxy-3-descladinose derivatives of erythromycins A and B
|
FR2742757B1
(fr)
*
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2751656B1
(fr)
*
|
1996-07-24 |
1998-10-16 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
WO1998009978A1
(en)
*
|
1996-09-04 |
1998-03-12 |
Abbott Laboratories |
6-o-substituted ketolides having antibacterial activity
|
UA51730C2
(ru)
*
|
1996-09-04 |
2002-12-16 |
Ебботт Лабораторіз |
6-0-замещённые кетолиды с антибактериальной активностью
|
FR2757168B1
(fr)
*
|
1996-12-12 |
1999-06-11 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2760017B1
(fr)
*
|
1997-02-27 |
1999-04-30 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
|
US5922683A
(en)
*
|
1997-05-29 |
1999-07-13 |
Abbott Laboratories |
Multicyclic erythromycin derivatives
|
JP2000513026A
(ja)
*
|
1997-06-11 |
2000-10-03 |
ファイザー・プロダクツ・インク |
9−オキシム エリスロマイシン誘導体
|
US5780604A
(en)
*
|
1997-09-26 |
1998-07-14 |
Abbott Laboratories |
11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
|
US6034069A
(en)
*
|
1997-09-30 |
2000-03-07 |
Abbott Laboratories |
3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
|
US6124269A
(en)
*
|
1997-10-29 |
2000-09-26 |
Abbott Laboratories |
2-Halo-6-O-substituted ketolide derivatives
|
US6046171A
(en)
*
|
1997-10-29 |
2000-04-04 |
Abbott Laboratories |
6,11-bridged erythromycin derivatives
|
JP2004514643A
(ja)
*
|
1997-10-29 |
2004-05-20 |
大正製薬株式会社 |
エリスロマイシンa誘導体
|
ZA989835B
(en)
*
|
1997-10-29 |
1999-05-05 |
Taisho Pharmaceutical Co Ltd |
Erythromycin a derivatives
|
HRP980189B1
(en)
*
|
1998-04-06 |
2004-04-30 |
Pliva Pharm & Chem Works |
Novel 15-membered lactams ketolides
|
FR2777282B1
(fr)
*
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
JP4573925B2
(ja)
*
|
1998-07-09 |
2010-11-04 |
アベンティス・ファーマ・ソシエテ・アノニム |
新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
|
FR2781484B1
(fr)
*
|
1998-07-21 |
2001-08-10 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
|
WO2000017218A1
(en)
|
1998-09-22 |
2000-03-30 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
FR2785612A1
(fr)
*
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
TR200200435T2
(tr)
*
|
1998-11-03 |
2002-07-22 |
Pfizer Products Inc. |
Yeni makrolit antibiyotikler.
|
FR2786188B1
(fr)
*
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
TR200102129T2
(tr)
|
1998-12-10 |
2002-01-21 |
Pfizer Products Inc. |
Karbamat ve karbazat ketolid antibiyotikleri.
|
HUP0105190A3
(en)
|
1999-01-27 |
2003-03-28 |
Pfizer Prod Inc |
Ketolide antibiotics, medicaments containing them and their use
|
FR2789392B1
(fr)
*
|
1999-02-04 |
2001-10-05 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
US6054435A
(en)
*
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
KR100710605B1
(ko)
|
1999-04-16 |
2007-04-24 |
코산 바이오사이언시즈, 인코포레이티드 |
매크롤라이드 항감염제
|
US6939861B2
(en)
*
|
1999-04-16 |
2005-09-06 |
Kosan Biosciences, Inc. |
Amido macrolides
|
US6514944B2
(en)
|
1999-04-16 |
2003-02-04 |
Kosan Biosciences, Inc. |
Macrolide antiinfective agents
|
US6451768B1
(en)
|
1999-04-16 |
2002-09-17 |
Kosan Biosciences, Inc. |
Macrolide antiinfective agents
|
US6590083B1
(en)
|
1999-04-16 |
2003-07-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Ketolide antibacterials
|
HRP990116B1
(en)
*
|
1999-04-20 |
2007-10-31 |
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. |
NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
|
JP2003500414A
(ja)
*
|
1999-05-24 |
2003-01-07 |
ファイザー・プロダクツ・インク |
13−メチルエリスロマイシン誘導体
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
EP1146051A3
(en)
*
|
2000-04-10 |
2001-10-31 |
Pfizer Products Inc. |
Erythromycin A derivatives
|
US8063021B2
(en)
*
|
2002-01-17 |
2011-11-22 |
Kosan Biosciences Incorporated |
Ketolide anti-infective compounds
|
US7273853B2
(en)
*
|
2002-05-13 |
2007-09-25 |
Enanta Pharmaceuticals, Inc. |
6-11 bicyclic ketolide derivatives
|
US7129221B2
(en)
*
|
2002-05-13 |
2006-10-31 |
Enanta Pharmaceuticals, Inc. |
6,11-bicyclic erythromycin derivatives
|
US6764998B1
(en)
|
2003-06-18 |
2004-07-20 |
Enanta Pharmaceuticals, Inc. |
6,11-4C-bicyclic 9a-azalide derivatives
|
US7910558B2
(en)
*
|
2002-05-13 |
2011-03-22 |
Enanta Pharmaceuticals, Inc. |
Bridged macrocyclic compounds and processes for the preparation thereof
|
US6878691B2
(en)
*
|
2002-05-13 |
2005-04-12 |
Enanta Pharmaceuticals, Inc. |
6-11 bicyclic ketolide derivatives
|
US7135573B2
(en)
*
|
2002-05-13 |
2006-11-14 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
|
US6841664B2
(en)
*
|
2002-07-25 |
2005-01-11 |
Enanra Pharmaceuticals, Inc. |
6,11-4-carbon bridged ketolides
|
US7064110B2
(en)
*
|
2002-05-13 |
2006-06-20 |
Enanta Pharmaceuticals, Inc. |
6-11 bicycle ketolide derivatives
|
WO2005070918A1
(en)
*
|
2002-05-13 |
2005-08-04 |
Enanta Pharmaceuticals, Inc. |
Process for the preparation of t-11 bicyclic erythromycin derivatives
|
US6753318B1
(en)
*
|
2002-07-25 |
2004-06-22 |
Enanta Pharmaceuticals, Inc. |
6,11-4-carbon bridged erythromycin derivatives
|
TW200420573A
(en)
*
|
2002-09-26 |
2004-10-16 |
Rib X Pharmaceuticals Inc |
Bifunctional heterocyclic compounds and methods of making and using same
|
HRP20020779A2
(en)
|
2002-09-27 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
|
CN1780846A
(zh)
*
|
2003-03-05 |
2006-05-31 |
Rib-X医药品有限公司 |
双官能杂环化合物及其制备和使用方法
|
US7601695B2
(en)
|
2003-03-10 |
2009-10-13 |
Optimer Pharmaceuticals, Inc. |
Antibacterial agents
|
US6645941B1
(en)
|
2003-03-26 |
2003-11-11 |
Enanta Pharmaceuticals, Inc. |
6,11-3C-bicyclic 9a-azalide derivatives
|
WO2005007143A2
(en)
*
|
2003-07-14 |
2005-01-27 |
The Board Of Trustees Of The University Of Illinois |
Use of makrolides and ketolides for the treatment of tuberculosis
|
WO2005030227A1
(en)
*
|
2003-09-23 |
2005-04-07 |
Enanta Pharmaceuticals, Inc. |
9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
|
WO2005042554A1
(en)
*
|
2003-10-30 |
2005-05-12 |
Rib-X Pharmaceuticals, Inc. |
Bifunctional macrolide heterocyclic compounds and methods of making and using the same
|
JP2007512256A
(ja)
*
|
2003-11-18 |
2007-05-17 |
リブ−エックス ファーマシューティカルズ,インコーポレイテッド |
二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
|
US7414030B2
(en)
*
|
2004-01-07 |
2008-08-19 |
Enanta Pharmaceuticals, Inc. |
6-11 Bicyclic erythromycin derivatives
|
WO2005070113A2
(en)
*
|
2004-01-09 |
2005-08-04 |
Enanta Pharmaceuticals, Inc. |
9n-substituted 6-11 bicyclic erythromycin derivatives
|
US8202843B2
(en)
|
2004-02-27 |
2012-06-19 |
Rib-X Pharmaceuticals, Inc. |
Macrocyclic compounds and methods of making and using the same
|
EP2233493A1
(en)
*
|
2004-12-21 |
2010-09-29 |
Pfizer Products Inc. |
Macrolides
|
AU2006205828A1
(en)
*
|
2005-01-12 |
2006-07-20 |
Alpharma Aps |
Erythromycin derivatives as antibacterial agents
|
US7384922B2
(en)
*
|
2005-05-04 |
2008-06-10 |
Enanta Pharmaceuticals, Inc. |
6-11 bridged oxime erythromycin derivatives
|
WO2006129257A2
(en)
*
|
2005-05-30 |
2006-12-07 |
Ranbaxy Laboratories Limited |
Ketolide derivatives as antibacterial agents
|
EP1779849A1
(en)
*
|
2005-10-28 |
2007-05-02 |
Nikem Research S.R.L. |
V-ATPase inhibitors for the treatment of septic shock
|
CN100424089C
(zh)
*
|
2006-01-18 |
2008-10-08 |
中国药科大学 |
一种制备大环内酯类半合成抗生素泰利霉素的方法
|
US8273720B2
(en)
*
|
2007-09-17 |
2012-09-25 |
Enanta Pharmaceuticals, Inc. |
6,11-bicyclolides: bridged biaryl macrolide derivatives
|
CA2699733C
(en)
*
|
2007-09-17 |
2013-01-22 |
Enanta Pharmaceuticals, Inc. |
6,11-bridged biaryl macrolides
|
US8354383B2
(en)
*
|
2007-09-17 |
2013-01-15 |
Enanta Pharmaceuticals, Inc. |
6,11-bridged biaryl macrolides
|
WO2009055557A1
(en)
|
2007-10-25 |
2009-04-30 |
Cempra Pharmaceuticals, Inc. |
Process for the preparation of macrolide antibacterial agents
|
EP2220104A1
(en)
*
|
2007-10-25 |
2010-08-25 |
Sandoz AG |
Process for the production of telithromycin
|
TW200946109A
(en)
*
|
2008-05-09 |
2009-11-16 |
Enanta Pharm Inc |
Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
|
US8796232B2
(en)
|
2008-10-24 |
2014-08-05 |
Cempra Pharmaceuticals, Inc. |
Methods for treating resistant diseases using triazole containing macrolides
|
US9937194B1
(en)
|
2009-06-12 |
2018-04-10 |
Cempra Pharmaceuticals, Inc. |
Compounds and methods for treating inflammatory diseases
|
JP5914335B2
(ja)
|
2009-09-10 |
2016-05-11 |
センプラ ファーマシューティカルズ,インコーポレイテッド |
マラリア、結核、及びmac病の治療方法
|
WO2011119604A1
(en)
|
2010-03-22 |
2011-09-29 |
Cempra Pharmaceuticals, Inc. |
Crystalline forms of a macrolide, and uses therefor
|
BR112012029586A2
(pt)
|
2010-05-20 |
2016-08-02 |
Cempra Pharmaceuticals Inc |
processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
|
KR20180110181A
(ko)
*
|
2010-09-10 |
2018-10-08 |
셈프라 파마슈티컬스, 인크. |
질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
|
DE102010055322A1
(de)
*
|
2010-12-21 |
2012-06-21 |
Christian-Albrechts-Universität Zu Kiel |
Antibakteriell und antimykotisch wirkende Substanzen
|
CA2868262A1
(en)
|
2012-03-27 |
2013-10-03 |
Cempra Pharmaceuticals, Inc. |
Parenteral formulations for administering macrolide antibiotics
|
CN105163785A
(zh)
|
2013-03-14 |
2015-12-16 |
森普拉制药公司 |
用于治疗呼吸道疾病的方法及其制剂
|
CA2907085A1
(en)
|
2013-03-15 |
2014-09-18 |
Cempra Pharmaceuticals, Inc. |
Convergent processes for preparing macrolide antibacterial agents
|